» Articles » PMID: 25666623

LINGO-1 Protein Interacts with the P75 Neurotrophin Receptor in Intracellular Membrane Compartments

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2015 Feb 11
PMID 25666623
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Axon outgrowth inhibition in response to trauma is thought to be mediated via the binding of myelin-associated inhibitory factors (e.g. Nogo-66, myelin-associated glycoprotein, oligodendrocyte myelin glycoprotein, and myelin basic protein) to a putative tripartite LINGO-1·p75(NTR)·Nogo-66 receptor (NgR) complex at the cell surface. We found that endogenous LINGO-1 expression in neurons in the cortex and cerebellum is intracellular. Mutation or truncation of the highly conserved LINGO-1 C terminus altered this intracellular localization, causing poor intracellular retention and increased plasma membrane expression. p75(NTR) associated predominantly with natively expressed LINGO-1 containing immature N-glycans, characteristic of protein that has not completed trans-Golgi-mediated processing, whereas mutant forms of LINGO-1 with enhanced plasma membrane expression did not associate with p75(NTR). Co-immunoprecipitation experiments demonstrated that LINGO-1 and NgR competed for binding to p75(NTR) in a manner that is difficult to reconcile with the existence of a LINGO-1·p75(NTR)·NgR ternary complex. These findings contradict models postulating functional LINGO-1·p75(NTR)·NgR complexes in the plasma membrane.

Citing Articles

B-cells expressing NgR1 and NgR3 are localized to EAE-induced inflammatory infiltrates and are stimulated by BAFF.

Bakhuraysah M, Theotokis P, Lee J, Alrehaili A, Aui P, Figgett W Sci Rep. 2021; 11(1):2890.

PMID: 33536561 PMC: 7858582. DOI: 10.1038/s41598-021-82346-6.


Opicinumab: is it a potential treatment for multiple sclerosis?.

Ahmed Z, Fulton D, Douglas M Ann Transl Med. 2020; 8(14):892.

PMID: 32793736 PMC: 7396746. DOI: 10.21037/atm.2020.03.131.


Revising the mechanism of p75NTR activation: intrinsically monomeric state of death domains invokes the "helper" hypothesis.

Goncharuk S, Artemieva L, Nadezhdin K, Arseniev A, Mineev K Sci Rep. 2020; 10(1):13686.

PMID: 32792564 PMC: 7427093. DOI: 10.1038/s41598-020-70721-8.


Electroacupuncture Promoting Axonal Regeneration in Spinal Cord Injury Rats via Suppression of Nogo/NgR and Rho/ROCK Signaling Pathway.

Xiao W, Ding L, Min Y, Yang H, Yao H, Sun J Neuropsychiatr Dis Treat. 2020; 15:3429-3442.

PMID: 31997879 PMC: 6918258. DOI: 10.2147/NDT.S216874.


Functional activity of anti-LINGO-1 antibody opicinumab requires target engagement at a secondary binding site.

Hanf K, Arndt J, Liu Y, Gong B, Rushe M, Sopko R MAbs. 2020; 12(1):1713648.

PMID: 31928294 PMC: 6973334. DOI: 10.1080/19420862.2020.1713648.


References
1.
Golbang A, Cope G, Hamad A, Murthy M, Liu C, Cuthbert A . Regulation of the expression of the Na/Cl cotransporter by WNK4 and WNK1: evidence that accelerated dynamin-dependent endocytosis is not involved. Am J Physiol Renal Physiol. 2006; 291(6):F1369-76. DOI: 10.1152/ajprenal.00468.2005. View

2.
Fu Y, Subramanya A, Rozansky D, Cohen D . WNK kinases influence TRPV4 channel function and localization. Am J Physiol Renal Physiol. 2006; 290(6):F1305-14. DOI: 10.1152/ajprenal.00391.2005. View

3.
Lee X, Yang Z, Shao Z, Rosenberg S, Levesque M, Pepinsky R . NGF regulates the expression of axonal LINGO-1 to inhibit oligodendrocyte differentiation and myelination. J Neurosci. 2007; 27(1):220-5. PMC: 6672289. DOI: 10.1523/JNEUROSCI.4175-06.2007. View

4.
Urra S, Escudero C, Ramos P, Lisbona F, Allende E, Covarrubias P . TrkA receptor activation by nerve growth factor induces shedding of the p75 neurotrophin receptor followed by endosomal gamma-secretase-mediated release of the p75 intracellular domain. J Biol Chem. 2007; 282(10):7606-15. DOI: 10.1074/jbc.M610458200. View

5.
Inoue H, Lin L, Lee X, Shao Z, Mendes S, Snodgrass-Belt P . Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease models. Proc Natl Acad Sci U S A. 2007; 104(36):14430-5. PMC: 1955463. DOI: 10.1073/pnas.0700901104. View